Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis
Abstract Background Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia mediated by IgM autoantibodies that trigger hemolysis via classical complement pathway. Increased incidence of thrombotic events (TEs) has been reported in patients with other forms of hemolysis. The incidence of...
Main Authors: | Catherine M. Broome, Julia M. Cunningham, Megan Mullins, Xiaohui Jiang, Lauren C. Bylsma, Jon P. Fryzek, Adam Rosenthal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-05-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12333 |
Similar Items
-
Cold agglutinin disease: current challenges and future prospects
by: Berentsen S, et al.
Published: (2019-04-01) -
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
by: Sigbjørn Berentsen
Published: (2020-04-01) -
Cold Agglutinin Disease
by: Amy P. Gabbard, et al.
Published: (2020-07-01) -
Laparoscopic cholecystectomy for cold agglutinin syndrome with gallstones: a case report
by: WANG Bin, et al.
Published: (2017-04-01) -
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
by: Irina Murakhovskaya
Published: (2020-12-01)